In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Sabra Health Care REIT's current price of $19.16 is significantly below the PERT-weighted fair value of $34.44, indicating potential undervaluation with implied upside near 80%. Despite fair financial health scores and moderate leverage, Monte Carlo analysis reveals high valuation volatility (144.46% coefficient of variation) but no downside risk below current price. Diverse valuation methods suggest mixed assumptions, with DCF and analyst targets varying widely, reflecting growth and valuation uncertainties.